Atlas Trials

Evaluate Tolerability and Safety of HY209 in Healthy Volunteers

Clinical trial NCT06533878 · UNKNOWN

Trial details

NCT number
NCT06533878
Sponsor
Kukjeon Pharmaceutical Co.,Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Dementia
Start date
2023-09-13
Primary completion
2024-12-31
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.